Article
Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.
European journal of clinical pharmacology - 1 Dec 2016
Hu Miao, Lee Hon-Kit, To Kenneth K W, Fok Benny S P, Wo Siu-Kwan, Ho Chung-Shun, Wong Chun-Kwok, Zuo Zhong, Chan Thomas Y K, Chan Juliana C N, Tomlinson Brian
Abstract excerpt
PURPOSE: The ATP-binding cassette transporter G2 (ABCG2) plays an important role in the disposition of rosuvastatin. Telmisartan, a selective angiotension-II type 1 (AT1) receptor blocker, inhibits the transport capacity of ABCG2, which may result in drug interactions. This study investigated the pharmacokinetic interaction between rosuvastatin and telmisartan and the potential mechanism. METHODS: In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
